Depression – Mild to Moderate

To evaluate the efficacy, safety, and tolerability for adjunctive treatment of MDD.

  • male or female 18-65 years of age
  • current major depression episode of 8 weeks to 24 months in duration
  • failure to respond less than 50% improvement to an adequate trial of anti-depressant in the current episode.
  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.